seri
benzylthio
sarscov
proteas
inhibitor
develop
potenc
evalu
vitro
proteas
inhibitori
assay
two
candid
encourag
result
develop
new
antisar
compound
seri
benzylthio
sarscov
proteas
inhibitor
develop
potenc
evalu
vitro
proteas
inhibitori
assay
two
candid
encourag
result
develop
new
antisar
compound
elsevi
ltd
right
reserv
sever
acut
respiratori
syndrom
sar
recogn
global
threat
sar
character
high
fever
malais
rigor
headach
chill
cough
progress
radiograph
chang
chest
lymphophenia
initi
outbreak
sar
first
identifi
guangdong
provinc
china
novemb
outbreak
spread
sever
countri
signific
health
econom
impact
mortal
rate
nearli
rigor
effort
world
health
organ
research
found
sar
caus
novel
coronaviru
sarscov
sarscov
positivestrand
rna
viru
genom
kb
strain
genom
constitut
five
major
open
read
frame
name
replicas
polyprotein
nucleocapsid
protein
spike
envelop
e
membran
glycoprotein
result
structur
function
studi
coronavir
lifecycl
provid
number
signific
target
ceas
viral
replic
viral
replic
replicas
polyprotein
undergo
extens
process
two
viral
proteas
name
chymotrypsinlik
proteas
pro
papainlik
proteas
pl
pro
resid
within
polyprotein
catalyz
releas
polyprotein
nonstructur
protein
nsp
polyprotein
initi
viru
mediat
rna
replic
essenti
role
viral
replic
proteas
recogn
attract
target
develop
antisar
agent
date
variou
sarscov
proteas
inhibitor
report
screen
compound
librari
design
compound
base
substrat
structur
activ
site
properti
scaffold
divers
includ
c
symmetr
diol
acid
deriv
deriv
cinanserin
calmodulin
ketoglutamin
analogu
anilid
bifunct
boron
acid
compound
isatin
deriv
benzotriazol
well
glutam
acid
glutamin
peptid
possess
trifluoromethyl
keton
group
bunsatur
ester
etacryn
acid
deriv
metalconjug
structur
molecul
make
coordin
bond
activ
site
sarscov
pro
howev
effect
therapi
develop
far
recent
isol
strain
sarscov
emphas
possibl
reemerg
therefor
still
great
challeng
explor
new
chemic
class
sarscov
pro
inhibitor
use
antisar
therapi
case
diseas
reemerg
previou
studi
high
throughput
screen
identifi
variou
heterocycl
novel
antisar
agent
select
inhibit
rang
ic
lm
sarscov
proteas
compound
fig
paper
part
ongo
effort
delin
complet
pharmacophor
model
design
sever
benzylthio
deriv
antisar
agent
compound
fig
synthet
point
view
prepar
target
compound
envis
follow
synthet
rout
illustr
scheme
synthesi
prepar
reaction
substitut
benzaldehyd
ethyl
cyanoacet
thiourea
use
literatur
procedur
regioselect
salkyl
achiev
slow
addit
respect
halid
solut
dmf
see
front
matter
elsevi
ltd
right
reserv
use
k
co
base
yield
correspond
compound
analyt
spectral
data
target
compound
accord
structur
target
compound
test
antisar
activ
sarscov
pro
use
previous
develop
assay
method
contain
lm
sar
pro
lm
fluorogen
substrat
dabcylktsavlqsgfrkmeedan
lm
test
compound
enhanc
fluoresc
reaction
buffer
mm
bistri
ph
monitor
nm
excit
nm
use
fluoresc
plate
reader
compound
inhibit
proteas
activ
lm
select
next
assay
run
lm
ic
calcul
compound
r
group
nitro
function
posit
potent
inhibitor
enzym
inhibitori
activ
sarscov
pro
ic
lm
structur
ic
valu
given
tabl
cytotox
test
compound
test
perform
mtt
assay
found
compound
devoid
cytotox
obtain
molecular
insight
bind
properti
activ
compound
conduct
dock
studi
pro
activ
site
model
analysi
crystal
structur
sar
pro
complex
peptid
inhibitor
pdb
code
use
dock
process
perform
use
autom
liganddock
subprogram
discoveri
studio
model
sbd
accelri
inc
san
diego
ca
set
paramet
chosen
control
precis
oper
genet
algorithm
dock
run
carri
use
standard
default
set
grid
resolut
site
open
bind
site
select
defin
activ
site
caviti
search
obtain
model
associ
complex
compound
protein
distanc
nh
pyrimidin
ring
oxygen
atom
constrain
distanc
orient
ligand
nitro
phenyl
group
situat
pocket
nitro
group
point
toward
surfac
protein
one
oxygen
nitro
group
close
proxim
oxygen
atom
form
hydrogen
bond
distanc
fig
chlorophenyl
ring
fit
pocket
hydrophob
interact
result
dock
studi
present
suggest
nitro
phenyl
group
potenti
occupi
activ
site
cystein
residu
enzym
oxygen
nitro
group
form
hydrogen
bond
side
chain
import
inhibit
activ
compound
lack
nitro
function
aryl
ring
lost
activ
moder
electron
withdraw
substitu
r
like
chloro
compound
favor
inhibitori
activ
compar
electron
donat
group
like
methyl
methoxi
compound
see
tabl
result
suggest
substitu
r
electron
withdraw
group
increas
inhibitori
action
conclus
disclos
inhibitori
potenc
compound
contain
pyrimidin
unit
sarscov
pro
inhibitor
measur
inhibitori
activ
coupl
possibl
structur
modif
reveal
dock
give
us
new
direct
fast
develop
much
potent
inhibitor
investig
new
famili
compound
current
progress
laboratori
